Kuhle J - Search Results

1

FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.

Mehling M, Brinkmann V, Antel J, Bar-Or A, Goebels N, Vedrine C, Kristofic C, Kuhle J, Lindberg RL, Kappos L. Mehling M, et al. Among authors: kuhle j. Neurology. 2008 Oct 14;71(16):1261-7. doi: 10.1212/01.wnl.0000327609.57688.ea. Neurology. 2008. PMID: 18852441

2

Alternatives to current disease-modifying treatment in MS: what do we need and what can we expect in the future?

Kappos L, Kuhle J, Gass A, Achtnichts L, Radue EW. Kappos L, et al. Among authors: kuhle j. J Neurol. 2004 Sep;251 Suppl 5:v57-v64. doi: 10.1007/s00415-004-1509-6. J Neurol. 2004. PMID: 15549357 Review.

3

Genomics and proteomics: role in the management of multiple sclerosis.

Kappos L, Achtnichts L, Dahlke F, Kuhle J, Naegelin Y, Sandbrink R, Lindberg RL. Kappos L, et al. Among authors: kuhle j. J Neurol. 2005 Sep;252 Suppl 3:iii21-iii27. doi: 10.1007/s00415-005-2013-3. J Neurol. 2005. PMID: 16170496 Review.

4

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Kuhle J, et al. N Engl J Med. 2007 Jan 25;356(4):371-8. doi: 10.1056/NEJMoa063602. N Engl J Med. 2007. PMID: 17251533 Free article. Clinical Trial.

5

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

Kuhle J, Lindberg RL, Regeniter A, Mehling M, Hoffmann F, Reindl M, Berger T, Radue EW, Leppert D, Kappos L. Kuhle J, et al. J Neurol. 2007 Feb;254(2):160-8. doi: 10.1007/s00415-006-0299-4. J Neurol. 2007. PMID: 17334662

6

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.

Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L. Lindberg RL, et al. Among authors: kuhle j. J Neuroimmunol. 2008 Feb;194(1-2):153-64. doi: 10.1016/j.jneuroim.2007.11.007. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178259

7

10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system.

Mehling M, Kuhle J, Regeniter A. Mehling M, et al. Among authors: kuhle j. Neurologist. 2008 Jan;14(1):60-5. doi: 10.1097/NRL.0b013e31815ac523. Neurologist. 2008. PMID: 18195662 Review. No abstract available.

8

Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central nervous system involvement.

Mehling M, Drechsler H, Kuhle J, Hardmeier M, Doerries R, Ruegg S, Gass A. Mehling M, et al. Among authors: kuhle j. J Neurovirol. 2008 Jan;14(1):78-84. doi: 10.1080/13550280701793940. J Neurovirol. 2008. PMID: 18300078

9

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN; BG-12 Phase IIb Study Investigators. Kappos L, et al. Lancet. 2008 Oct 25;372(9648):1463-72. doi: 10.1016/S0140-6736(08)61619-0. Lancet. 2008. PMID: 18970976 Clinical Trial.

10

A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting.

Regeniter A, Kuhle J, Mehling M, Möller H, Wurster U, Freidank H, Siede WH. Regeniter A, et al. Among authors: kuhle j. Clin Neurol Neurosurg. 2009 May;111(4):313-8. doi: 10.1016/j.clineuro.2008.12.004. Epub 2009 Jan 30. Clin Neurol Neurosurg. 2009. PMID: 19185983 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

480 results

Search Page

Filters